Our mission is to unleash the power of personalized medicine.

TheraCea develops radioligands as diagnostic and therapeutic tools for the faster and more accurate detection of neurological disorders and more effective treatment of cancers.

TheraCea has partnered with the National Science Foundation and National Institutes of Health to move the technology from the chemistry bench to clinics. 

“Treat What You See”